Novartis AG ADR (NVSN)

Mexico


	Symbol		Exchange		Currency
	NVS		NYSE		USD	Real-time
	NOVNz		BATS Europe		CHF	Delayed
	NVSEF		OTC Markets		USD	Delayed
	0QLR		London		CHF	Real-time
	NVSN		Mexico		MXN	Delayed
	NOVNEE		Switzerland		CHF	Delayed
	NOVN		Switzerland		CHF	Delayed
	NVSy		TradeGate		EUR	Delayed
	NVSm		Buenos Aires		ARS	Delayed
	N1VS34		B3		BRL	Delayed

Currency in MXN

Disclaimer

2,193.74

+66.74(+3.14%)

Closed04:59:59

Fair Value

Day's Range

2,193.74

2,193.74

52 wk Range

1,540.00

2,193.74

NVSN Income Statement

Featured here, the Income Statement (earnings report) for Novartis AG ADR, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

48,677

49,898

43,974

43,461

46,660

Total Revenues Growth

+5.59%

+2.51%

-11.87%

-1.17%

+7.36%

Cost Of Revenues

14,425

15,121

11,391

11,297

12,020

Gross Profit

34,252

34,777

32,583

32,164

34,640

Gross Profit Growth

+8.43%

+1.53%

-6.31%

-1.29%

+7.7%

Gross Profit Margin %

70.37%

69.7%

74.1%

74.01%

74.24%

Other Operating Expenses, Total

25,166

24,625

21,620

20,955

21,998

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+11.03%	-2.15%	-12.2%	-3.08%	+4.98%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	9,402	8,980	8,259	8,425	9,011
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	14,369	14,197	12,756	12,143	12,489
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,395	1,448	605	387	498

Operating Income

9,086

10,152

10,963

11,209

12,642

Operating Income Growth

+1.82%

+11.73%

+7.99%

+2.24%

+12.78%

EBIT Margin %

18.67%

20.35%

24.93%

25.79%

27.09%

Net Interest Expenses

-605

-778

-717

-423

-228

Net Interest Expenses Growth

+5.47%

-28.6%

+7.84%

+41%

+46.1%

Interest Expense, Total

-850

-869

-787

-800

-855

Interest And Investment Income

245

91

70

377

627

Other Non Operating Expenses, Total

459

504

15,229

-248

-210

EBT, Excl. Unusual Items

8,940

9,878

25,475

10,538

12,204

Gain (Loss) On Sale Of Assets

-

-

724

166

225

Other Unusual Items, Total

-

-

-880

-1,445

-2,250

EBT, Incl. Unusual Items

8,940

9,878

24,530

7,177

9,123

EBT, Incl. Unusual Items Growth

-36.57%

+10.49%

+148.33%

-70.74%

+27.11%

EBT, Incl. Unusual Items Margin

18.37%

19.8%

55.78%

16.51%

19.55%

Income Tax Expense

1,793

1,807

1,625

1,128

551

Net Income to Company

11,737

8,071

24,018

6,955

14,854

Minority Interest

-5

1

3

-

-4

Net Income

11,732

8,072

24,021

6,955

14,850

Net Income Growth

-6.97%

-31.2%

+197.58%

-71.05%

+113.52%

Net Income Margin %

24.1%

16.18%

54.63%

16%

31.83%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

7,142

8,072

22,908

6,049

8,568

Basic EPS - Continuing Operations

3.12

3.54

10.21

2.77

4.13

Basic EPS - Continuing Operations Growth

-43.49%

+13.7%

+188.15%

-72.85%

+48.76%

Diluted EPS - Continuing Operations

3.08

3.52

10.14

2.76

4.1

Diluted EPS - Continuing Operations Growth

-43.59%

+14.29%

+188.07%

-72.78%

+48.55%

Basic Weighted Average Shares Outstanding

2,290.79

2,277.04

2,242.6

2,181.18

2,076.79

Diluted Weighted Average Shares Outstanding

2,319

2,296

2,260

2,197

2,092

Dividend Per Share

3.12

3.39

3.4

3.46

3.92

Dividend Per Share Growth

+9.86%

+8.68%

+0.29%

+1.77%

+13.24%

EBITDA

13,267

14,932

15,633

15,936

17,518

EBITDA Growth

-6.14%

+12.55%

+4.69%

+1.94%

+9.93%

EBITDA Margin %

27.26%

29.93%

35.55%

36.67%

37.54%

EBIT